Literature DB >> 19152458

Postpartum spontaneous colonic perforation due to antiphospholipid syndrome.

Kamran Ahmed1, Amir Darakhshan, Eleanor Au, Munther A Khamashta, Iraklis E Katsoulis.   

Abstract

The antiphospholipid syndrome (APS) is a multi-systemic disease being characterized by the presence of antiphospholipid antibodies that involves both arterial and venous systems resulting in arterial or venous thrombosis, fetal loss, thrombocytopenia, leg ulcers, livedo reticularis, chorea, and migraine. We document a previously unreported case of a 37-year-old female in whom APS was first manifested by infarction and cecal perforation following cesarean section. At laparotomy the underlying cause of colonic perforation was not clear and after resection of the affected bowel an ileo-colostomy was performed. The diagnosis of APS was established during post-operative hospital stay and the patient was commenced on warfarin. Eventually, she made a full recovery and had her stoma reversed after 4 mo. Pregnancy poses an increased risk of complications in women with APS and requires a more aggressive approach to the obstetric care. This should include full anticoagulation in the puerperium and frequent doppler ultrasound monitoring of uterine and umbilical arteries to detect complications such as pre-eclampsia and placental insufficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19152458      PMCID: PMC2653374          DOI: 10.3748/wjg.15.502

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  The anticardiolipin syndrome.

Authors:  T Danao; E G Camara
Journal:  Am Fam Physician       Date:  1989-01       Impact factor: 3.292

2.  Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies.

Authors:  S R Sangle; W Jan; I S Lau; A N Bennett; G R V Hughes; D P D'Cruz
Journal:  Clin Exp Rheumatol       Date:  2006 May-Jun       Impact factor: 4.473

3.  Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications.

Authors:  E K Insko; Z J Haskal
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

Review 4.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

5.  Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome.

Authors:  H J Lee; J W Park; J C Chang
Journal:  J Gastroenterol Hepatol       Date:  1997-12       Impact factor: 4.029

6.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

7.  Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA.

Authors:  S Takeuchi; T Obayashi; J Toyama
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

8.  Immunological specificity and mechanism of action of IgG lupus anticoagulants.

Authors:  V Pengo; P Thiagarajan; S S Shapiro; M J Heine
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

9.  Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.

Authors:  E Angles-Cano; Y Sultan; J P Clauvel
Journal:  J Lab Clin Med       Date:  1979-08

10.  Human platelet-immune complex interaction in plasma.

Authors:  W F Clark; G J Tevaarwerk; B D Reid
Journal:  J Lab Clin Med       Date:  1982-12
View more
  1 in total

1.  Primary cecal pathologies presenting as acute abdomen and critical appraisal of their current management strategies in emergency settings with review of literature.

Authors:  Singh Mathuria Kaushal-Deep; Afzal Anees; Shehtaj Khan; Mohammad Amanullah Khan; Mehershree Lodhi
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.